Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Feasibility and Safety of Walking Football in Patients With Type 2 Diabetes

20 août 2019 mis à jour par: Romeu Mendes, Universidade do Porto
Our main challenge is to develop a novel physical activity intervention to promote exercise participation sustainability and effective health benefits in type 2 diabetes (T2D) population with minimum health risks. The relevance of this study is supported by four cornerstones: 1) The Portuguese love football and there seems to be a major potential in the implementation of football practice as part of the prevention and treatment of noncommunicable diseases for the middle-aged and elderly Portuguese population; 2) no studies have assessed the feasibility and safety of a walking football exercise program for middle-age and older patients with T2D; 3) the proposed investigation relies on robust methodology; 4) this intervention can have further sustainability with the enrollment of football clubs and primary health care units.

Aperçu de l'étude

Statut

Complété

Les conditions

Description détaillée

This work will be a quasi-experimental study where we aim to test the feasibility and safety of walking football in patients with T2D. The recruitment of participants will be held in primary health care units by Family Medicine medical doctors. All participants will receive instructions to maintain daily-life routines (lifestyle-related physical activity and dietary pattern), and to continue with usual care (diabetes consultations on primary health care units and pharmacological regimen) along the studies duration. All participants will receive basic sports material (sports bag, T-shirt, and sports shoes). Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety (acute effects on capillary glycaemia, blood pressure, foot impact, exercise-related injuries and adverse events) and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Cumulative short-term effects will also be analyzed along the three months through pre- and post-study evaluations. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

Type d'étude

Interventionnel

Inscription (Réel)

40

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Porto, Le Portugal, 4050-600
        • Instituto de Saúde Pública da Universidade do Porto

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

50 ans à 70 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Homme

La description

Inclusion Criteria:

  • diagnosis of type 2 diabetes for at least 12 months;
  • glycated hemoglobin bellow 10 %;
  • not having started insulin therapy in the previous six months;
  • not having started therapy with sulfonylureas in the previous six months;
  • major complications of diabetes screened and controlled (diabetic retinopathy, diabetic nephropathy and diabetic foot);
  • no symptoms of coronary artery disease;
  • no cardiovascular, respiratory and musculoskeletal contraindications to exercise;
  • not under cancer treatment (radiotherapy or intravenous chemotherapy);
  • without limitations in gait or balance;
  • independent living in the community;
  • not engaged in supervised exercise;
  • non-smokers at least for 6 months.

Exclusion Criteria:

  • cardiological stress test with cardiac or hemodynamic problems

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Exercise
Walking football exercise program
Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Exercise intensity - subjective internal load
Délai: Through 3 months
OMNI rating of perceived exertion scale during exercise (0 [lowest] to 10 [highest] points)
Through 3 months
Exercise intensity - objective internal load
Délai: Through 3 months
Heart rate during exercise
Through 3 months
Exercise intensity - external load
Délai: Through 3 months
Distance (km) assessed using GPS tracking during exercise
Through 3 months
Acute glycemic effect
Délai: Change between before and immediately after each exercise session
Acute change in capillary blood glucose with exercise sessions
Change between before and immediately after each exercise session
Acute systolic blood pressure effect
Délai: Change between before and immediately after each exercise session
Acute change in systolic blood pressure with exercise sessions
Change between before and immediately after each exercise session
Acute diastolic blood pressure effect
Délai: Change between before and immediately after each exercise session
Acute change in diastolic blood pressure with exercise sessions
Change between before and immediately after each exercise session
Incidence of falls
Délai: Through 3 months
Number of falls during the exercise program
Through 3 months
Incidence of foot injuries
Délai: Through 3 months
Number of reported foot injuries during the exercise program
Through 3 months
Incidence of musculoskeletal injuries
Délai: Through 3 months
Number of reported musculoskeletal injuries during the exercise program
Through 3 months
Rate of Enjoyment
Délai: Through 3 months
Self-reported exercise sessions' enjoyment on a likert scale (1 [lowest] to 5 [highest] points)
Through 3 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Glycemic control
Délai: Change from baseline to 3 months
Glycated hemoglobin (venous blood analysis)
Change from baseline to 3 months
Blood lipid profile
Délai: Change from baseline to 3 months
Total cholesterol (venous blood analysis)
Change from baseline to 3 months
Clinical systolic blood pressure
Délai: Change from baseline to 3 months
Resting systolic blood pressure
Change from baseline to 3 months
Clinical diastolic blood pressure
Délai: Change from baseline to 3 months
Resting diastolic blood pressure
Change from baseline to 3 months
Body mass index
Délai: Change from baseline to 3 months
Body mass index
Change from baseline to 3 months
Waist circumference
Délai: Change from baseline to 3 months
Waist circumference
Change from baseline to 3 months
Body fat
Délai: Change from baseline to 3 months
Body fat (bioelectrical impedance analysis)
Change from baseline to 3 months
Body lean mass
Délai: Change from baseline to 3 months
Body lean mass (bioelectrical impedance analysis)
Change from baseline to 3 months
Agility/balance
Délai: Change from baseline to 3 months
Timed Up and Go Test
Change from baseline to 3 months
Habitual physical activity
Délai: Change from baseline to 3 months
Global Physical Activity Questionnaire
Change from baseline to 3 months
Food pattern
Délai: Change from baseline to 3 months
24h-food recall analysis
Change from baseline to 3 months
Cognitive state
Délai: Change from baseline to 3 months
Montreal Cognitive Assessment score (0 [lowest] to 30 [highest] points)
Change from baseline to 3 months
Health-related quality of life
Délai: Change from baseline to 3 months
EQ-5D-5L questionnaire score (0 [lowest] to 100 [highest] points)
Change from baseline to 3 months
Medication
Délai: Change from baseline to 3 months
Number of medications
Change from baseline to 3 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Romeu Mendes, MD, PhD, EPIUnit - Instituto de Saúde Pública, Universidade do Porto

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

  • Barbosa A, Brito J, Costa J, Ramos E, Firmino-Machado J, Seabra A, Figueiredo P, Sá MJ, Lunet N, Mendes R. SWEET-FOOTBALL: Development of an evidence-based walking football program for middle-aged and older patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 32.
  • Barbosa A, Brito J, Sá MJ, Puga F, Firmino-Machado J, Seabra A, Figueiredo P, Ramos E, Lunet N, Mendes R. Adherence and enjoyment of a walking-football program for patients with type 2 diabetes: SWEET-FOOTBALL Project. In: Bunc V, Tsolakidis E, editors. Book of Abstracts of the 24th Annual Congress of the European College of Sport Science. Prague: ECSS; 2019. p. 120-1.
  • Rago V, Brito J, Costa J, Barbosa A, Figueiredo P, Seabra A, Travassos B, Mendes R. Activity profile during walking football training sessions in patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern University; 2019. p. 41.
  • Costa J, Brito J, Barbosa A, Figueiredo P, Seabra A, Sá MJ, Firmino-Machado J, Ramos E, Mendes R. Nocturnal cardiac autonomic activity in patients with type 2 diabetes engaged in a walking football programme. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 39.
  • Barbosa A, Brito J, Costa J, Figueiredo P, Seabra A, Mendes R. Feasibility and safety of a walking football program in middle-aged and older men with type 2 diabetes. Prog Cardiovasc Dis. 2020 Nov-Dec;63(6):786-791. doi: 10.1016/j.pcad.2020.06.014. Epub 2020 Jul 4.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

17 septembre 2018

Achèvement primaire (Réel)

31 janvier 2019

Achèvement de l'étude (Réel)

30 juin 2019

Dates d'inscription aux études

Première soumission

10 janvier 2019

Première soumission répondant aux critères de contrôle qualité

16 janvier 2019

Première publication (Réel)

22 janvier 2019

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

22 août 2019

Dernière mise à jour soumise répondant aux critères de contrôle qualité

20 août 2019

Dernière vérification

1 août 2019

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner